General Information of Drug Off-Target (DOT) (ID: OTLKYGW4)

DOT Name Nuclear receptor-interacting protein 2 (NRIP2)
Gene Name NRIP2
Related Disease
Colorectal carcinoma ( )
UniProt ID
NRIP2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF09668
Sequence
MLFIFPLSLPWRPSCWKESCSTGQRQAGRSREDSVTPPPSSPWPTPPAGAMSTKQEARRD
EGEARTRGQEAQLRDRAHLSQQRRLKQATQFLHKDSADLLPLDSLKRLGTSKDLQPRSVI
QRRLVEGNPNWLQGEPPRMQDLIHGQESRRKTSRTEIPALLVNCKCQDQLLRVAVDTGTQ
YNRISAGCLSRLGLEKRVLKASAGDLAPGPPTQVEQLELQLGQETVVCSAQVVDAESPEF
CLGLQTLLSLKCCIDLEHGVLRLKAPFSELPFLPLYQEPGQ
Function Down-regulates transcriptional activation by nuclear receptors such as NR1F2.

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Colorectal carcinoma DIS5PYL0 Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Nuclear receptor-interacting protein 2 (NRIP2). [2]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Nuclear receptor-interacting protein 2 (NRIP2). [3]
------------------------------------------------------------------------------------

References

1 Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting ROR.Mol Cancer. 2017 Jan 31;16(1):20. doi: 10.1186/s12943-017-0590-2.
2 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
3 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.